Pasithea Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$0.56

+0.03 (+6.44%)

As of Jun 30, 4:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +4,707.1% upside

Low Target $19.73

Average Target $26.92

High Target $29.00

Current Price $0.56

Current
$0.56

Target
$26.92

$19.73 $26.92 avg $29.00

Scenario Analysis

Bear Case

$19.73

3,423.2%

Low target

Base Case

$26.92

+4,707.1%

Avg target

Bull Case

$29.00

+5,078.6%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$2.06

-72.8% from high

52-Week Low

$0.28

+99.3% from low

Target vs 52W High

$26.92

+1,206.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%